U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06942910) titled 'A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria' on April 17.
Brief Summary: A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants with Chronic Kidney Disease and High Proteinuria (ZODIAC)
Study Start Date: April 28
Study Type: INTERVENTIONAL
Condition:
Chronic Kidney Disease With High Proteinuria
Intervention:
DRUG: Zibotentan/Dapagliflozin
Participants will receive zibotentan/dapagliflozin in fixed-dose combination as per...